Innovent & Lilly release clinical trial results of sintilimab injection

China-based Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and...

August 10, 2020 | Monday | News
Eli Lilly & HPL launch once-a-week T2D drug in Bangladesh

Bangladesh based Healthcare Pharmaceuticals Ltd. (HPL) and Eli Lilly & Company recently announced the...

August 10, 2020 | Monday | News
Taiwan approves new drug for early breast cancer treatment

China based CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat u...

August 10, 2020 | Monday | News
ImmVira, Shanghai Pharma to commercialize novel immunotherapies

ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboration and excl...

August 7, 2020 | Friday | News
Australian develops effective Triple Therapy to treat COVID-19

Australia's The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, D...

August 6, 2020 | Thursday | News
Colorcon opens new technical centre in Melbourne

US based Colorcon, a world leader in the development and supply of film coating systems and excipients, has announced th...

August 7, 2020 | Friday | News
Asahi Kasei to commercialize HA nanogel as pharmaceutical excipient

Tokyo based Asahi Kasei has established industrial manufacturing technology for hyaluronic acid (HA) nanogel as a new ph...

August 7, 2020 | Friday | News
3t Energy Group launches world's most technologically advanced platform

The world’s most technologically advanced, cloud-based workforce management and training platform Transform is bei...

August 4, 2020 | Tuesday | News
Sanofi, GSK to supply up to 300 M COVID-19 vaccine doses to EU

Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses ...

August 5, 2020 | Wednesday | News
COVID R&D Alliance announces first patients enrollment in I-SPY trial

Recently, members of the COVID R&D Alliance AbbVie, Inc. (ABBV), Amgen Inc. (AMGN), and Takeda Pharmaceutical Co. Lt...

August 4, 2020 | Tuesday | News
PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC

South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...

August 5, 2020 | Wednesday | News
G1, Simcere to bring new cancer therapy in Greater China

US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...

August 6, 2020 | Thursday | News
Takeda announces results for first quarter of fiscal 2020

Japan-based Takeda Pharmaceutical Company Limited (Takeda) recently announced financial results for the first quarter of...

August 3, 2020 | Monday | News
Takeda receives U.S. FDA Breakthrough Therapy Designation for Pevonedistat

Takeda Pharmaceutical Company Limited on 30 July 2020 announced that the U.S. Food and Drug Administration (FD...

July 30, 2020 | Thursday | News
Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody

Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...

August 3, 2020 | Monday | News
Novartis to strengthen future of antibiotics manufacturing in Europe

Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together wi...

August 4, 2020 | Tuesday | News
J&J to commence Ph III trial of COVID-19 vaccine in Sept

American multinational corporation Johnson & Johnson (J&J) has announced that its lead vaccine candidate pr...

August 3, 2020 | Monday | News
Hisun's Favipiravir supports Middle East in fighting COVID-19

  According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...

July 31, 2020 | Friday | News
Henlius & Accord Healthcare receives EMA approval for Zercepac®

The European Commission (EC) has approved Shanghai-based Henlius Biotech, Inc. and Accord Healthcare Limited (Accor...

July 30, 2020 | Thursday | News
Austrianova files Drug Master File with FDA for Cell-in-a-Box products from HEK293 cells

S.E. Asian company, Austrianova, headquartered in Singapore, announced on 28 July 2020 that it has filed a Drug Mas...

July 28, 2020 | Tuesday | News
A strong signal in turbulent times: Vetter achieves carbon dioxide-neutral levels

Focus on energy-efficient and environmentally friendly technology All European sites utilize green electricity Savin...

July 29, 2020 | Wednesday | News
Dynavax, Medigen to develop adjuvanted COVID-19 vaccine candidate

US based Dynavax Technologies Corporation, a biopharmaceutical company focused on developing and commercializing novel v...

July 30, 2020 | Thursday | News
Novavax, Fujifilm to manufacture COVID-19 vaccine at large scale

US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...

July 30, 2020 | Thursday | News
Henlius, Accord receive EMA approval for Zercepac®, trastuzumab biosimilar

Shanghai Henlius Biotech, Inc. announced that Marketing Authorization Application (“MAA”) for HLX02 (trastuz...

July 29, 2020 | Wednesday | News
Foresee announces submission of NDA for FDA approval of LMIS 50 mg

Taiwan and US-based biopharmaceutical company, Foresee Pharmaceuticals Co., Ltd. (Foresee), recently announced that...

July 29, 2020 | Wednesday | News